Sign in
4

Changes in Ownership

GeneDx Holdings Corp. Filed Acc 0001944119-25-000003

CHIEF FINANCIAL OFFICER sold 3,728 shares at $121.47 ($452,850)

  • CHIEF FINANCIAL OFFICER acquired 7,197 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Feeley Kevin CHIEF FINANCIAL OFFICER 2025-09-16 Option exercise −7,197 12,483 D: show line 1 in the form
Feeley Kevin CHIEF FINANCIAL OFFICER 2025-09-16 Sale −3,728 $121.47 $452,850 8,755 D: show line 2 in the form
Open-market sales · 3,728 sh · avg $121.47 · $452,850

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Feeley Kevin CHIEF FINANCIAL OFFICER 2025-09-16 Option exercise · Restricted Stock Unit −7,197 43,181 D: show line 3 in the form
Loading xslF345X05/form4-09182025_100926.xml…